BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Frenette C, Gish R. Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications. World J Gastroenterol 2012; 18(6): 498-506 [PMID: 22363115 DOI: 10.3748/wjg.v18.i6.498]
URL: https://www.wjgnet.com/1948-5182/full/v18/i6/498.htm
Number Citing Articles
1
Seulki Lee, Minjong Lee, Jong Bin Kim, Ara Jo, Eun Ju Cho, Su Jong Yu, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signalingBiochemical and Biophysical Research Communications 2016; 473(4): 1247 doi: 10.1016/j.bbrc.2016.04.049
2
ZS Guo, CL Jin, ZJ Yao, YM Wang, BT Xu. Analysis of the mitochondrial 4977 bp deletion in patients with hepatocellular carcinomaBalkan Journal of Medical Genetics 2017; 20(1): 81 doi: 10.1515/bjmg-2017-0006
3
JEHOON YANG, KYOUNG DOO SONG, JAE-HUN KIM, GEUN-HO IM, SEULGI YOON, MISUN NAMGUNG, JUNG-HYUN HWANG, JUNG HEE LEE, DONGIL CHOI. Characterization of brivanib therapy response in hepatocellular carcinoma xenografts using 1H HR-MAS spectroscopy and histopathologyMolecular Medicine Reports 2013; 8(5): 1425 doi: 10.3892/mmr.2013.1690
4
Amanda Psyrri, Nikolaos Arkadopoulos, Maria Vassilakopoulou, Vassilios Smyrniotis, George Dimitriadis. Pathways and targets in hepatocellular carcinomaExpert Review of Anticancer Therapy 2012; 12(10): 1347 doi: 10.1586/era.12.113
5
Roberta Montalbano, Petra Waldegger, Karl Quint, Samir Jabari, Daniel Neureiter, Romana Illig, Matthias Ocker, Pietro Di Fazio. Endoplasmic Reticulum Stress Plays a Pivotal Role in Cell Death Mediated by the Pan-Deacetylase Inhibitor Panobinostat in Human Hepatocellular Cancer CellsTranslational Oncology 2013; 6(2): 143 doi: 10.1593/tlo.12271
6
Samantha A. Armstrong, Aiwu Ruth He. Immuno-oncology for Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 739 doi: 10.1016/j.cld.2020.07.007
7
Jean-Marc Idée, Boris Guiu. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A reviewCritical Reviews in Oncology/Hematology 2013; 88(3): 530 doi: 10.1016/j.critrevonc.2013.07.003
8
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular LevelBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
9
Ruifang Wang, Xiaobo Hu, Xiaorui Liu, Lu Bai, Junsheng Gu, Qinggang Li, Edwin Wang. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysisPLOS ONE 2021; 16(4): e0249881 doi: 10.1371/journal.pone.0249881
10
Raewyn M. Poole, Asha Vaidya. Ramucirumab: First Global ApprovalDrugs 2014; 74(9): 1047 doi: 10.1007/s40265-014-0244-2
11
Ping Fang, Jin-hua Hu, Zhi-gang Cheng, Zhe-feng Liu, Jin-liang Wang, Shun-chang Jiao, Xiaolin Zi. Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II TrialsPLoS ONE 2012; 7(12): e49717 doi: 10.1371/journal.pone.0049717
12
Nitin Ohri, Andreas Kaubisch, Madhur Garg, Chandan Guha. Targeted Therapy for Hepatocellular CarcinomaSeminars in Radiation Oncology 2016; 26(4): 338 doi: 10.1016/j.semradonc.2016.06.004
13
Gaurab Roy, Su Guan, Hexiang Liu, Lei Zhang. Rotundic Acid Induces DNA Damage and Cell Death in Hepatocellular Carcinoma Through AKT/mTOR and MAPK PathwaysFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00545
14
Brian I. Carr. Some New Approaches to the Management of Hepatocellular CarcinomaSeminars in Oncology 2012; 39(4): 369 doi: 10.1053/j.seminoncol.2012.05.007
15
Jianzhen Lin, Liangcai Wu, Xue Bai, Yuan Xie, Anqiang Wang, Haohai Zhang, Xiaobo Yang, Xueshuai Wan, Xin Lu, Xinting Sang, Haitao Zhao. Combination treatment including targeted therapy for advanced hepatocellular carcinomaOncotarget 2016; 7(43): 71036 doi: 10.18632/oncotarget.11954
16
Chi-Yuan Chen, Chin-Chuan Chen, Wen-Yu Chuang, Yann-Lii Leu, Shir-Hwa Ueng, Chuen Hsueh, Chau-Ting Yeh, Tong-Hong Wang. Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer CellsFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00216
17
Takuji Okusaka, Taiga Otsuka, Hideki Ueno, Shuichi Mitsunaga, Rie Sugimoto, Kei Muro, Isao Saito, Yusuke Tadayasu, Kohei Inoue, Arsene-Bienvenu Loembé, Masafumi Ikeda. Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairmentCancer Science 2016; 107(12): 1791 doi: 10.1111/cas.13077
18
Nitin Ohri, Laura A. Dawson, Sunil Krishnan, Jinsil Seong, Jason C. Cheng, Shiv K. Sarin, Milan Kinkhabwala, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Chandan Guha. Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future StudyJournal of the National Cancer Institute 2016; 108(9): djw133 doi: 10.1093/jnci/djw133
19
Zhengyu Wei, Cataldo Doria, Yuan Liu. Targeted Therapies in the Treatment of Advanced Hepatocellular CarcinomaClinical Medicine Insights: Oncology 2013; 7: CMO.S7633 doi: 10.4137/CMO.S7633
20
Fang Su, Jun Zhao, Shukui Qin, Rui Wang, Yumei Li, Qiang Wang, Yi Tan, Hao Jin, Fangquan Zhu, Yurong Ou, Zenong Cheng, Wen Su, Fuyou Zhao, Yan Yang, Zhengguang Zhou, Jiyue Zheng, Yawei Li, Zhongwen Li, Qiong Wu. Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinomaOncotarget 2017; 8(14): 23277 doi: 10.18632/oncotarget.15054
21
Yusuke Shimodaira, Elena Elimova, Roopma Wadhwa, Hironori Shiozaki, Nikolaos Charalampakis, Venkatram Planjery, Mariela A Blum, Jeannelyn S Esteralla, Jane E Rogers, Shumei Song, Jaffer A Ajani. Ramucirumab for the treatment of gastroesophageal cancersExpert Opinion on Orphan Drugs 2015; 3(6): 737 doi: 10.1517/21678707.2015.1040390
22
KUO-SHYANG JENG, CHI-JUEI JENG, WEN-JUEI JENG, I-SHYAN SHEEN, SHIH-YUN LI, ZIH-HANG HUNG, HSIN-I HSIAU, MING-CHE YU, CHIUNG-FANG CHANG. Liver epithelial cells inhibit proliferation and invasiveness of hepatoma cellsOncology Reports 2016; 35(3): 1622 doi: 10.3892/or.2015.4478
23
Stefano Colagrande, Francesco Regini, Gian Giacomo Taliani, Cosimo Nardi, Andrea Lorenzo Inghilesi. Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upWorld Journal of Hepatology 2015; 7(8): 1041-1053 doi: 10.4254/wjh.v7.i8.1041
24
Mohammed K. AbdElhameid, Madlen B. Labib, Ahmed T. Negmeldin, Muhammad Al-Shorbagy, Manal R. Mohammed. Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2InhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry 2018; 33(1): 1472 doi: 10.1080/14756366.2018.1503654
25
Maria Luisa Bondì, Chiara Botto, Erika Amore, Maria Rita Emma, Giuseppa Augello, Emanuela Fabiola Craparo, Melchiorre Cervello. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cellsInternational Journal of Pharmaceutics 2015; 493(1-2): 75 doi: 10.1016/j.ijpharm.2015.07.055
26
Michael S Nastasie, Helmut Thissen, David A Jans, Kylie M Wagstaff. Enhanced tumour cell nuclear targeting in a tumour progression modelBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1045-z
27
Max M. Wattenberg, Nevena Damjanov, David E. Kaplan. Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experienceCancer Medicine 2019; 8(4): 1442 doi: 10.1002/cam4.2015
28
Christophe Duvoux, Christian Toso. mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?Transplantation Reviews 2015; 29(3): 168 doi: 10.1016/j.trre.2015.02.003
29
Sally Temraz, Ali T. Taher. Liver Cancer in the Middle East2021; : 375 doi: 10.1007/978-3-030-78737-0_24
30
Giovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, Stefano Di Donato, Marianna Silletta, Paolo Gallo, Angelo Onorato, Umberto Vespasiani-Gentilucci, Antonio Picardi. Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver CirrhosisCurrent Drug Metabolism 2020; 21(11): 866 doi: 10.2174/1389200221999200918141239
31
Malek Kreidieh, Youssef H. Zeidan, Ali Shamseddine. The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver TumorsJournal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4304817
32
Anna C. Krelle, Arinze S. Okoli, George L. Mendz. Huh-7 Human Liver Cancer Cells: A Model System to Understand Hepatocellular Carcinoma and TherapyJournal of Cancer Therapy 2013; 4(02): 606 doi: 10.4236/jct.2013.42078
33
Andrzej Krol, Barjor Gimi, Qian Liang, Jinzuo Ye, Yang Du, Chongwei Chi, Jie Tian. Evaluation of the anti-neoplastic effect of sorafenib on liver cancer through bioluminescence tomography Medical Imaging 2017: Biomedical Applications in Molecular, Structural, and Functional Imaging 2017; 10137: 1013702 doi: 10.1117/12.2254323
34
Tamer Elbaz, Mohamed El Kassas, Gamal Esmat. Management of Hepatocellular Carcinoma: Updated ReviewJournal of Cancer Therapy 2013; 4(02): 536 doi: 10.4236/jct.2013.42067
35
Giuseppe Aprile, Marta Bonotto, Elena Ongaro, Carmelo Pozzo, Francesco Giuliani. Critical Appraisal of Ramucirumab (IMC-1121B) for Cancer Treatment: From Benchside to Clinical UseDrugs 2013; 73(18): 2003 doi: 10.1007/s40265-013-0154-8
36
Marco Baron Toaldo, Veronica Salvatore, Sara Marinelli, Chiara Palamà, Maddalena Milazzo, Luca Croci, Laura Venerandi, Mario Cipone, Luigi Bolondi, Fabio Piscaglia. Use of VEGFR-2 Targeted Ultrasound Contrast Agent for the Early Evaluation of Response to Sorafenib in a Mouse Model of Hepatocellular CarcinomaMolecular Imaging and Biology 2015; 17(1): 29 doi: 10.1007/s11307-014-0764-x
37
Qi-Zhe Gong, Di Xiao, Gui-Yi Gong, Jian Xu, Xiao-Dong Wen, Feng Feng, Wei Qu. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling PathwayCurrent Cancer Drug Targets 2019; 19(7): 583 doi: 10.2174/1568009619666181226094814